Man Group plc - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Man Group plc ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,436,636
-16.9%
163,947
-34.5%
0.02%
-28.1%
Q1 2023$8,945,758
+2.7%
250,301
+8.6%
0.03%
+3.2%
Q4 2022$8,706,929
+10.8%
230,525
+29.8%
0.03%
-13.9%
Q3 2022$7,855,000
+1677.1%
177,597
+1388.7%
0.04%
+1700.0%
Q2 2022$442,000
+50.3%
11,930
+92.3%
0.00%
+100.0%
Q3 2020$294,000
-95.7%
6,204
-94.7%
0.00%
-97.1%
Q2 2020$6,840,000
+1390.2%
116,012
+1096.0%
0.03%
+1033.3%
Q1 2020$459,000
-87.0%
9,700
-83.5%
0.00%
-75.0%
Q4 2019$3,544,000
+9.0%
58,670
+8.2%
0.01%0.0%
Q3 2019$3,250,000
-39.0%
54,248
-34.6%
0.01%
-36.8%
Q2 2019$5,331,000
+214.0%
82,955
+296.5%
0.02%
+216.7%
Q1 2019$1,698,000
+513.0%
20,924
+308.4%
0.01%
+500.0%
Q4 2018$277,000
-55.5%
5,124
-57.6%
0.00%
-50.0%
Q3 2018$623,000
-17.5%
12,077
-33.3%
0.00%
-33.3%
Q2 2018$755,000
+271.9%
18,109
+293.7%
0.00%
+200.0%
Q1 2018$203,0004,6000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders